rs61738625
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_001282225.2(ADA2):āc.1467G>Cā(p.Glu489Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000917 in 1,612,710 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001282225.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADA2 | NM_001282225.2 | c.1467G>C | p.Glu489Asp | missense_variant | 10/10 | ENST00000399837.8 | NP_001269154.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADA2 | ENST00000399837.8 | c.1467G>C | p.Glu489Asp | missense_variant | 10/10 | 1 | NM_001282225.2 | ENSP00000382731 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000506 AC: 77AN: 152202Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000398 AC: 100AN: 251338Hom.: 0 AF XY: 0.000397 AC XY: 54AN XY: 135850
GnomAD4 exome AF: 0.000960 AC: 1402AN: 1460508Hom.: 1 Cov.: 29 AF XY: 0.000921 AC XY: 669AN XY: 726644
GnomAD4 genome AF: 0.000506 AC: 77AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.000309 AC XY: 23AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | Jul 11, 2022 | DNA sequence analysis of the ADA2 gene demonstrated a sequence change, c.1467G>C, in exon 10 that results in an amino acid change, p.Glu489Asp. This sequence change does not appear to have been previously described in individuals with ADA2-related disorders. This sequence change has been described in the gnomAD database with a frequency of 0.075% in the European subpopulation (dbSNP rs61738625). The p.Glu489Asp change affects a poorly conserved amino acid residue located in a domain of the ADA2 protein that is known to be functional. The p.Glu489Asp substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Glu489Asp change remains unknown at this time. - |
Vasculitis due to ADA2 deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 28, 2023 | This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 489 of the ADA2 protein (p.Glu489Asp). This variant is present in population databases (rs61738625, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with ADA2-related conditions. ClinVar contains an entry for this variant (Variation ID: 569098). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The aspartic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Autoinflammatory syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Jan 22, 2021 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | ADA2: BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at